<DOC>
	<DOCNO>NCT00491374</DOCNO>
	<brief_summary>This study hope show treatment patient 's perennial allergic rhinitis ( PAR ) use Nasonex® ( mometasone furoate nasal spray ) result improvement nasal symptom PAR nighttime sleep-disordered breathing , thereby result improve sleep quality , less daytime sleepiness , improve daytime functioning , improve quality life .</brief_summary>
	<brief_title>Study Nasonex® Improving Sleep Disturbances Related Perennial Allergic Rhinitis ( Study P04909 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>1 . Must 18 45 year age , either sex , race . 2 . Must least 2year history PAR . 3 . Must skin test positive usual allergen associate PAR within previous 12 month regular exposure least one allergens subject allergic . 4 . Must sufficiently symptomatic Screening Visit ( Visit 1 ) , Qualification Visit ( Visit 2 ) , Baseline Visit ( Visit 4 ) minimal level PRIOR ( reflective ) total symptom score , total nasal symptom score , total nonnasal symptom score order qualify . 5 . At Qualification Visit 2 , subject must score least 2 Interference Sleep severity rating score least 3 7 night prior Qualification visit . 6 . At Baseline Visit 4 subject must score least 2 Interference Sleep severity rating score least 1 3 night prior Baseline Visit . 7 . Must apneahypopnea index ( AHI ) &gt; =5 , 30 , first screen polysomnographic evaluation proceed second polysomnographic evaluation . 8 . At Baseline Visit ( Visit 4 ) , subject must complete NRQLQ , PQSI , ESS , WPAIAS . 9 . Must complete PVT within 1 hour bedtime 1 hour arise night PSGs do . 10 . Female subject childbearing potential ( include woman less 1 year postmenopausal woman sexually active study ) must agree use medically accept method contraception surgically sterilize prior screen , receive protocolspecified medication , 30 day stop medication . Women postmenopausal &gt; 1 year ( ie , woman experience 12 consecutive month amenorrhea ) exempt use contraception study . 11 . Female subject childbearing potential must negative urine pregnancy test Screening ( Visit 1 ) negative urine pregnancy test Visit 4 confirm prior dose study drug final Visit 7 . 1 . Subject symptomatic seasonal allergic rhinitis ( SAR ) history SAR calendar period study . 2 . Subject female pregnant , intend become pregnant study . 3 . Subject nursing , intend nursing study . 4 . Subject use investigational product within 30 day prior enrollment antibody asthma allergic rhinitis past 90 day ) . 5 . Subject follow clinical condition : know severe sleep apnea asthma chronic obstructive pulmonary disease ( COPD ) alcohol abuse rhinitis medicamentosa 6 . Subject currently antihistamine , decongestant ( topical systemic ) nasal inhale corticosteroid 14 day prior Screening Visit . 7 . Subject current history frequent episode ( 2 episode per year past 2 year ) clinically significant sinusitis chronic purulent postnasal drip . 8 . Subject recent nasal septum ulcer , nasal surgery , nasal trauma . 9 . Subject upper low respiratory tract sinus infection require antibiotic therapy last dose 14 day prior screen , viral upper low respiratory infection within 14 day prior screen . 10 . Subject nasal structural abnormality , include large nasal polyp , mark septum deviation significantly interfere nasal airflow . 11 . Subject unable refrain regular use nasal , oral ocular decongestant , nasal topical antihistamine , nasal steroid . 12 . Subject immunotherapy ( desensitization therapy ) receive increase dose study . Subjects may receive desensitization treatment within 24 hour prior study visit . 13 . Subject active quiescent tuberculosis infection respiratory tract , untreated fungal , bacterial , systemic viral infection , ocular herpes simplex . 14 . Subject morbidly obese ( BMI &gt; =35 ) . 15 . Subject nightshift worker standard asleep night / awake day cycle , irregular sleep/wake schedule . 16 . Subject report routinely spend less 6 1/2 hour time bed per night . 17 . Subject report drink 3 cup regular coffee 4 8 ounce cans/bottles caffeinecontaining carbonate beverage per 24 hour period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>